COMP <GO>
PBH vs HCM // EV/EBITDA & P/E VALUATION
Prestige Consumer Healthcare Inc. (NYSE) VS. HUTCHMED (China) Limited (NASDAQ) • 15-METRIC TALLY: PBH 7
— HCM 3
■ METRIC PARITY
LAST: $49.06 (+0.64%) • MKT CAP: $2.32B
valuation
7.0x
LAST: $13.15 (-3.24%) • MKT CAP: $2.29B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PBH VS. HCM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PBH | HCM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 54.70% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.80% | -2.50% | +16.30 | PBH | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 7.0x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 10.67% | -3.32% | +13.99 | PBH | /fcf-yield <GO> |
| Operating Margin | 28.40% | -7.10% | +35.50 | PBH | /operating-margins <GO> |
| Net Profit Margin | 17.50% | 68.00% | -50.50 | HCM | /net-margins <GO> |
| Revenue Growth (YoY) | -4.30% | -13.00% | +8.70 | PBH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.21 | 3.63 | -1.42 | HCM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | PBH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.0 | 42.4 | +11.60 | PBH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.3x | 4.8x | +6.50 | HCM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.32B | $2.29B | $30.0M | PBH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PBH REV | HCM REV | PBH GROSS % | HCM GROSS % | PBH FCF | HCM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.09B | $548.5M | 54.7% | 38.7% | $246.4M | -$78.8M |
| FY 2024 | $1.14B | $630.2M | 55.8% | 44.6% | $243.3M | -$17.4M |
| FY 2023 | $1.13B | $838.0M | — | — | $248.9M | $219.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PBH // BETA —
HCM // BETA —